OBJECTIVE: To evaluate whether a new documentation-based clinical decision support system (CDSS) is effective in addressing deficiencies in the care of patients with coronary artery disease (CAD) and diabetes mellitus (DM). STUDY DESIGN: Controlled trial randomized by physician. METHODS: We assigned primary care physicians (PCPs) in 10 ambulatory practices to usual care or the CAD/DM Smart Form for 9 months. The primary outcome was the proportion of deficiencies in care that were addressed within 30 days after a patient visit. RESULTS: The Smart Form was used for 5.6% of eligible patients. In the intention-to-treat analysis, patients of intervention PCPs had a greater proportion of deficiencies addressed within 30 days of a visit compared with controls (11.4% vs 10.1%, adjusted and clustered odds ratio =1.14; 95% confidence interval, 1.02-1.28; P = .02). Differences were more pronounced in the "on-treatment" analysis: 17.0% of deficiencies were addressed after visits in which the Smart Form was used compared with 10.6% of deficiencies after visits in which it was not used (P <.001). Measures that improved included documentation of smoking status and prescription of antiplatelet agents when appropriate. CONCLUSIONS: Overall use of the CAD/DM Smart Form was low, and improvements in management were modest. When used, documentation-based decision support shows promise, and future studies should focus on refining such tools, integrating them into current electronic health record platforms, and promoting their use, perhaps through organizational changes to primary care practices.
RCT Entities:
OBJECTIVE: To evaluate whether a new documentation-based clinical decision support system (CDSS) is effective in addressing deficiencies in the care of patients with coronary artery disease (CAD) and diabetes mellitus (DM). STUDY DESIGN: Controlled trial randomized by physician. METHODS: We assigned primary care physicians (PCPs) in 10 ambulatory practices to usual care or the CAD/DM Smart Form for 9 months. The primary outcome was the proportion of deficiencies in care that were addressed within 30 days after a patient visit. RESULTS: The Smart Form was used for 5.6% of eligible patients. In the intention-to-treat analysis, patients of intervention PCPs had a greater proportion of deficiencies addressed within 30 days of a visit compared with controls (11.4% vs 10.1%, adjusted and clustered odds ratio =1.14; 95% confidence interval, 1.02-1.28; P = .02). Differences were more pronounced in the "on-treatment" analysis: 17.0% of deficiencies were addressed after visits in which the Smart Form was used compared with 10.6% of deficiencies after visits in which it was not used (P <.001). Measures that improved included documentation of smoking status and prescription of antiplatelet agents when appropriate. CONCLUSIONS: Overall use of the CAD/DM Smart Form was low, and improvements in management were modest. When used, documentation-based decision support shows promise, and future studies should focus on refining such tools, integrating them into current electronic health record platforms, and promoting their use, perhaps through organizational changes to primary care practices.
Authors: P M Neri; L Redden; S Poole; C N Pozner; J Horsky; A S Raja; E Poon; G Schiff; A Landman Journal: Appl Clin Inform Date: 2015-01-21 Impact factor: 2.342
Authors: Gibril J Njie; Krista K Proia; Anilkrishna B Thota; Ramona K C Finnie; David P Hopkins; Starr M Banks; David B Callahan; Nicolaas P Pronk; Kimberly J Rask; Daniel T Lackland; Thomas E Kottke Journal: Am J Prev Med Date: 2015-11 Impact factor: 5.043
Authors: Gina R Kruse; Yuchiao Chang; Jennifer H K Kelley; Jeffrey A Linder; Jonathan S Einbinder; Nancy A Rigotti Journal: Am J Manag Care Date: 2013-07 Impact factor: 2.229
Authors: Kaveh G Shojania; Alison Jennings; Alain Mayhew; Craig R Ramsay; Martin P Eccles; Jeremy Grimshaw Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: Devin M Mann; Joseph L Kannry; Daniel Edonyabo; Alice C Li; Jacqueline Arciniega; James Stulman; Lucas Romero; Juan Wisnivesky; Rhodes Adler; Thomas G McGinn Journal: Implement Sci Date: 2011-09-19 Impact factor: 7.327
Authors: Jennifer Ennis; Daniel Gillen; Arthur Rubenstein; Elaine Worcester; Mark E Brecher; John Asplin; Fredric Coe Journal: BMC Nephrol Date: 2015-10-15 Impact factor: 2.388
Authors: Lianne Jeffs; Madelyn P Law; Sharon Straus; Roberta Cardoso; Renee F Lyons; Chaim Bell Journal: BMJ Qual Saf Date: 2013-07-12 Impact factor: 7.035
Authors: John G Lawrenson; Ella Graham-Rowe; Fabiana Lorencatto; Jennifer Burr; Catey Bunce; Jillian J Francis; Patricia Aluko; Stephen Rice; Luke Vale; Tunde Peto; Justin Presseau; Noah Ivers; Jeremy M Grimshaw Journal: Cochrane Database Syst Rev Date: 2018-01-15